NADH cytochrome b 5 reductase mediates electron transfer from NADH to cytochrome b 5 utilizing flavin adenine dinucleotide as a redox cofactor. Reduced cytochrome b 5 is an important cofactor in many metabolic reactions including cytochrome P450-mediated xenobiotic metabolism, steroid biosynthesis and fatty acid metabolism, hemoglobin reduction, and methionine and plasmalogen synthesis. Using recombinant human enzyme, we discovered that cytochrome b5 reductase mediates redox cycling of a variety of quinones generating superoxide anion, hydrogen peroxide, and, in the presence of transition metals, hydroxyl radicals. Redox cycling activity was oxygen-dependent and preferentially utilized NADH as a co-substrate; NADH was 5-10 times more active than NADPH in supporting redox cycling. Redox cycling activity was greatest for 9,10-phenanthrenequinone and 1,2-naphthoquinone, followed by 1,4-naphthoquinone and 2-methyl-1,4-naphthoquinone (menadione), nitrofurantoin and 2-hydroxyestradiol. Using menadione as the substrate, quinone redox cycling was found to inhibit reduction of cytochrome b 5 by cytochrome b 5 reductase, as measured by heme spectral changes in cytochrome b 5 . Under anaerobic conditions where redox cycling is inhibited, menadione had no effect on the reduction of cytochrome b 5 . Chemical redox cycling by cytochrome b 5 reductase may be important in generating cytotoxic reactive oxygen species in target tissues. This activity, together with the inhibition of cytochrome b 5 reduction by redox-active chemicals and consequent deficiencies in available cellular cytochrome b 5 , are likely to contribute to tissue injury following exposure to quinones and related redox active chemicals.
Introduction
Cytochrome b 5 reductase is an FAD-containing enzyme that mediates electron transfer from NADH to cytochrome b 5 (Elahian et al., 2014; Strittmatter, 1965) . Reduced cytochrome b 5 serves as a redox partner in an array of metabolic processes including cytochrome P450-mediated xenobiotic metabolism and steroid biosynthesis, fatty acid metabolism, hemoglobin reduction, and methionine and plasmalogen synthesis (Guengerich, 2005) . Cytochrome b 5 reductase/cytochrome b 5 has also recently been reported to reduce cytoglobin, a heme containing protein thought to be important in protecting cells against hypoxia (Amdahl et al., 2017) . The importance of cytochrome b 5 reductase in vivo is illustrated by findings that endoplasmic reticulum-associated b 5 knockout mice display phenotypic abnormalities that include alterations in hepatic fatty acid metabolism and the development of diabetes and lipoatrophy (Xu et al., 2011) . Genetic deficiencies in cytochrome b 5 reductase in humans have also been linked to methemoglobinemia which is associated with accumulation of oxidized Fe +3 and a reduced oxygen carrying capacity of blood as well as neurodevelopmental disorders (Fermo et al., 2008; Galeeva et al., 2013; Hudspeth et al., 2010; Nagai et al., 1993) . Earlier studies demonstrated that cytochrome b 5 reductase can mediate the one electron reduction of quinones to their semiquinone form (Iyanagi et al., 1984; Iyanagi and Yamazaki, 1969; Iyanagi and Yamazaki, 1970) . Semiquinone intermediates are unstable and donate an electron to diatomic oxygen, forming superoxide anion and https://doi.org/10.1016/j.taap.2018.09.011 Received 24 July 2018; Received in revised form 11 September 2018; Accepted 12 September 2018 returning to the native quinone state (O'Brien, 1991; see Fig. 1 for reaction scheme). The ability of a quinone to be reduced again by cytochrome b 5 reductase, cycling back and forth between redox states, a process referred to as chemical redox cycling or futile redox cycling, can result in tissue injury. The formation of superoxide anion through redox cycling generates cytotoxic oxidizing species including hydrogen peroxide (H 2 O 2 ), hydroxyl radicals and, in the presence of nitric oxide, peroxynitrite; in cells this process can lead to oxidative and/or nitrosative stress (Wink et al., 1997) . Quinone redox cycling is an energetically favorable reaction which can inhibit the enzymes mediating this process. For example, quinone redox cycling is also known to be mediated by NADPH cytochrome P450 reductase, an enzyme that donates electrons to the cytochrome P450s (Szilagyi et al., 2016) . Redox cycling preferentially uses electrons from NADPH at the expense of their supply to the cytochrome P450s which in turn inhibits their monooxygenase activities (Jan et al., 2015) . Similarly, sepiapterin reductase, the rate limiting enzyme in tetrahydrobiopterin biosynthesis, is a mediator of quinone redox cycling, a process that readily inhibits activity of this enzyme (Yang et al., 2013) . In the present studies, we characterized chemical redox cycling using recombinant human cytochrome b 5 reductase and determined if this process interferes with electron flow from NADH to cytochrome b 5 . The ability to generate reactive oxygen species as well as alter the reduction of cytochrome b 5 is likely to contribute to tissue injury induced by various redox active chemicals.
Materials and methods

Chemicals and reagents
Amplex red (10-acetyl-3,7-dihydroxyphenoxazine) was obtained from Invitrogen (Eugene, OR). Cytochrome b 5 , acetylated cytochrome c, 9,10-phenanthrenequinone, 2-methyl-1,4-naphthquinone (menadione), 1,4-naphthoquinone, nitrofurantoin (N-(5-nitro-2-furfurylidene)-1-aminohydantoin), 2-hydroxyestradiol, diethylenetriaminepentaacetic acid (DETAPAC) and all other chemicals were from Sigma-Aldrich (St. Louis, MO). Plasmid expressing recombinant Nterminal histidine tagged human cytochrome b 5 reductase was a generous gift of Dr. Lauren Trepanier (University of Wisconsin-Madison, Madison, WI). The enzyme was expressed in E. coli as previously described (Kurian et al., 2004) and purified using Ni-chromatography (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Stock solutions of the enzyme ranged from 1 to 4 mg/mL and were > 98% pure as determined by SDS-polyacrylamide gel electrophoresis followed by silver staining. The specific enzyme activity was assessed using the ferricyanide assay as previously published (Mihara and Sato, 1975) where 1 U of cytochrome b 5 reductase reduces 1 μmole of ferricyanide per min. Enzyme protein was quantified using the DC protein assay kit (Bio-Rad, Hercules, CA) with bovine serum albumin as the standard.
Enzyme assays
Unless otherwise stated, all assays were performed in 96-well flat bottom microwell plates at 37°C; changes in absorbance/fluorescence were measured using a SpectraMax M3 fluorescent microplate reader (Molecular Devices, Sunnyvale, CA). Data were collected using SoftMax Pro 6.3 software and analyzed using GraphPad Prism 5 (La Jolla, CA). Reactions were initiated using NADH or NADPH (200 μM final concentration) as reducing cofactors. Enzyme concentrations in reaction mixes ranged from 0.02-12 U/mL, as specified in figure legends.
Measurements of reactive oxygen species in enzyme assays
Changes in absorbance at 550 nm of acetylated cytochrome c were used to monitor production of superoxide anion (Azzi et al., 1975) . Briefly, reaction mixtures contained 100 mM potassium phosphate buffer (pH 7.8), 50 μM acetylated cytochrome c, 1 U/mL recombinant cytochrome b 5 reductase and 100 μM menadione in a final volume of 0.1 mL. Unless otherwise stated, reactions were initiated by the addition of NAD(P)H (200 μM). To demonstrate the specificity of the assay, superoxide dismutase (1000 U/mL) was used as a scavenger of superoxide anion. H 2 O 2 generation was measured using the continuous Amplex red/horseradish peroxidase method as previously described (Mishin et al., 2010) . Briefly, reaction mixtures contained 100 mM potassium phosphate buffer (pH 7.8), 0.2 U/mL recombinant cytochrome b 5 reductase, 100 μM Amplex red, 1 U/mL horseradish peroxidase, and redox cycling compounds in a final volume of 0.1 mL. Reactions were initiated by the addition of NAD(P)H. To demonstrate the specificity of the assay, catalase (1000 U/mL) was used as a scavenger of H 2 O 2 . The fluorescence increase due to formation of resorufin (excitation 535 nm/ emission 580 nm), was recorded, and the rates were calculated based on the linear phase of reactions after background subtraction. The terephthalate-based assay was used to measure the formation of hydroxyl radicals (Son et al., 2015) . In this assay, hydroxyl radicals are formed due to the reaction of H 2 O 2 with Fe 2+ and scavenged by the nonfluorescent substrate terephthalate, producing the fluorescent 2-hydroxyterephthalate (2-OH-TPT, excitation 315 nm/emission 425 nm). Reactions were run in the presence of 1 U/mL recombinant cytochrome b 5 reductase, 100 μM FeCl 3 , 110 μM EDTA and 1 mM terephthalate. To ) serves as a redox partner for a variety of enzymes including those mediating reduction of hemoglobin, xenobiotics and fatty acid/ lipid metabolism and steroid, plasmalogen and methionine biosynthesis. Cytochrome b 5 is maintained in the reduced state by cytochrome b 5 reductase at the expense of reducing equivalents supplied by NADH. Lower panel: Cytochrome b5 reductase also mediates chemical redox cycling. In this reaction, the enzyme forms semiquinone radicals from redox active quinones such as menadione (2-methyl-1,4-naphthoquinone) from electrons donated by NADH. Reaction of the semiquinone with molecular oxygen regenerates the parent compound and in the process, generates superoxide anion. Spontaneous and enzyme supported dismutation of superoxide anion generates H 2 O 2 and, in the presence of a transition metal, hydroxyl radicals. J.T. Szilagyi et al. Toxicology and Applied Pharmacology 359 (2018) 102-107 demonstrate the specificity of the assay, in some experiments DMSO (1%,~125 mM) was used as a trap for hydroxyl radicals.
Analysis of NAD(P)H consumption and oxygen utilization in enzyme assays
Oxygen uptake was measured using an Oxygraph Plus System fitted with a Clark-type oxygen electrode (Hansatech Instruments Ltd., UK) as previously described (Yang et al., 2013) . Decreases in absorbance at 340 nm were used to analyze the rates of NADH utilization initiated by cytochrome b 5 reductase (Bergmeyer, 1975) . Briefly, reaction mixtures contained 100 mM potassium phosphate buffer (pH 7.8), 1.0 mM sodium azide, 1.0 mM DETAPAC, and 600 μM NADH in a final volume of 0.1 ml. In these experiments the reactions were initiated by the addition of 1 U/mL cytochrome b 5 reductase. The oxidation state of heme can be characterized using visible-wavelength spectral analysis (Lewis, 1954; North et al., 1996) . The enzymatic reduction of cytochrome b 5 heme by cytochrome b 5 reductase results in a red shift of its Soret peak from 412 to 425 nm (see Fig. 4 ) (Aoyama et al., 1990; Arinc and Cakir, 1999; Strittmatter and Velick, 1956 ). Heme-binding difference spectra were recorded on the microplate reader as previously described (Szilagyi et al., 2016) . Reaction mixtures for all spectral measurements contained 100 mM potassium phosphate buffer (pH 7.5), 0.1% Triton X-100, 12 U/mL cytochrome b 5 reductase and 12 ng/mL cytochrome b 5 . Prior to the addition of NADH, each sample served as its own reference cuvette. Reaction mixtures were incubated in the dark and, after 10 min at room temperature, 200 μM NADH was added and the mixture incubated for an additional 10 min. The optical absorbance from 300 to 500 nm was before and after the addition of NADH. Difference spectra were generated by subtracting the absolute oxidized spectra from the absolute reduced spectra. Where applied, anaerobic conditions in the wells were generated by incubating reaction mixtures with 25 U/mL catalase, 50 mM glucose, and 12.5 U/mL glucose oxidase for 20 min prior to initiating spectral analysis (Penketh et al., 2015) .
Results
In initial studies, we characterized redox cycling by recombinant human cytochrome b 5 reductase. Redox cycling of quinones generates a semiquinone radical that reacts with molecular oxygen to regenerate the parent compound (O'Brien, 1991) . Using menadione as the redox active quinone, the enzyme was found to readily consume oxygen in the presence of NADH (Fig. 2A) . Both oxygen utilization and NADH consumption were time-dependent ( Figs. 2A-B) . The redox cycling process actively generated superoxide anion and H 2 O 2 (Fig. 2C-D) . Formation of reactive oxygen species was also dependent on time and the concentration of menadione. NADH was significantly more active in supplying reducing equivalents to cytochrome b 5 reductase for redox cycling when compared to NADPH (Fig. 2E) ; the rate of H 2 O 2 formation in the presence of menadione (100 μM) per unit of cytochrome b 5 reductase for NADH and NADPH was 595.8 ± 18.1 and 58.8 ± 7.8 pmole/min/U B 5 R (n = 3 ± SD), respectively. In the presence of Fe 3+ /EDTA complexes, redox cycling corresponded with generation of hydroxyl radicals (Fig. 2F) . Accumulation of superoxide anion and H 2 O 2 in redox cycling assays was abolished by superoxide dismutase and catalase, respectively, while hydroxyl radical production was inhibited by DMSO, a hydroxyl radical trap (Eberhardt and Colina, 1988) . Cytochrome b 5 reductase did not produce any detectable reactive oxygen species in the absence of a redox cycling agent (data not shown). Several additional redox active chemicals generated reactive oxygen species also by redox cycling with cytochrome b 5 reductase including 9,10-phenanthrenequinone, 1,4-naphthoquinone, and the catechol estrogen, 2-hydroxyestradiol and nitrofurantoin ( Fig. 3 and Table 1 ). Of these chemicals, 9,10-phenanthrenequinone was most active (Km = 5.7 μM, kcat = 5.8 min ). Cytochrome b 5 reductase-mediated redox cycling was also observed with other catechol estrogens, including 4-hydroxyestradiol, 4-hydroxyestrone and 2-hydroxyestriol. The parent estrogens, estradiol, estrone, and estriol, and the methoxy-estrogen metabolite 2-methoxyestradiol were not able to redox cycle with the enzyme (data not shown).
Cytochrome b 5 is an endogenous ligand for cytochrome b 5 reductase (Strittmatter, 1965) . As a heme-containing protein, reduction of cytochrome b 5 by cytochrome b 5 reductase can be monitored by difference spectroscopy (Aoyama et al., 1990; Strittmatter and Velick, 1956 ). In Fig. 4 . Spectral properties of oxidized and reduced cytochrome b 5 . Absolute spectra were recorded as described in Materials and Methods. Reaction mixtures contained 12 U/mL cytochrome b 5 reductase and 12 ng/mL cytochrome b 5 . Oxidized and reduced spectra were recorded in the presence and absence of NADH (200 μM final concentration), respectively. Reduction of cytochrome b 5 is characterized by a shift in its Soret peak from 414 to 425 nm (Mihara and Sato, 1975; Strittmatter, 1965) . Fig. 5 . Effects of redox cycling agents on the reduction of cytochrome b 5 by cytochrome b 5 reductase. Difference spectra were recorded as described in Materials and Methods. Reaction mixtures contained 12 U/mL cytochrome b 5 reductase, 12 ng/mL cytochrome b 5 , and menadione or 2OHE2 (Left panel, 10 μM; Center panel, 100 μM). The spectrum of each sample was recorded before and after the addition of NADH to a final concentration of 200 μM. Spectra in the absence of NADH for each sample served as the reference. Right panel, Reduction of cytochrome b 5 by cytochrome b 5 reductase in the presence and absence of menadione under aerobic and anaerobic conditions. Reaction mixtures contained 12 U/mL cytochrome b 5 reductase, 12 ng/mL cytochrome b 5 , and 100 μM menadione. Anaerobic conditions were generated in situ using the glucose/glucose oxidase method as described in Materials and Methods. J.T. Szilagyi et al. Toxicology and Applied Pharmacology 359 (2018) 102-107 this assay, reduction of cytochrome b 5 by cytochrome b 5 reductase results in a red shift of its Soret peak from 410 nm to 425 nm (Fig. 4 ) (Aoyama et al., 1990) . We found that by redox cycling with cytochrome b 5 reductase, both menadione (10 μM and 100 μM) and 2-hydroxyestradiol (100 μM) blocked reduction of cytochrome b 5 (Fig. 5A-B) . As redox cycling is oxygen-dependent, we next analyzed the effects of depleting oxygen on cytochrome b 5 -mediated reduction of cytochrome b 5 in reaction mixtures. In the presence of NADH, cytochrome b 5 reductase effectively supplied electrons to cytochrome b 5 under both aerobic and anaerobic conditions, as measured by distinctive changes in the cytochrome b 5 difference spectra. However, under anaerobic conditions, menadione was unable to inhibit the reduction of cytochrome b 5 (Fig. 5C ).
Discussion
The present studies demonstrate that a variety of redox active chemicals including quinones and nitrofurantoin, redox cycle with purified recombinant cytochrome b 5 reductase. These data are consistent with earlier studies using electron spin resonance, which demonstrated that cytochrome b 5 reductase catalyzes the one electron reduction of quinones including menadione Yamazaki, 1969, 1970) . The generation of reactive oxygen species during chemical redox cycling is an important mechanism contributing to tissue injury (Hochstein, 1983) . Hydroxyl radicals derived from superoxide anion and H 2 O 2 are highly reactive; modifications on cellular macromolecules can disrupt cellular function. Reactive oxygen species can also initiate lipid peroxidation, a process that can disrupt lipid membranes and generate cytotoxic lipid peroxidation end products. In addition to cytochrome b 5 reductase, a number of other enzymes have been reported to mediate redox cycling, including various aldo-keto reductases, nitric oxide synthases and thioredoxin reductases, cytochrome P450 reductase, sepiapterin reductase and dicarbonyl/l-xylulose reductase (Garner et al., 1999; Gray et al., 2007; Shultz et al., 2011; Szilagyi et al., 2016; Yang et al., 2013; Yang et al., 2017) . At the present time, the individual contributions of the enzymes to tissue injury in response to different quinones and other redox active chemicals as a consequence of redox cycling, is unknown. It is likely that toxicity depends, not only on the relative ability of individual enzymes to generate reactive oxygen species during redox cycling, but also on enzyme concentrations and their subcellular distribution in different cell types. In this regard, the ability of microsomal forms of cytochrome b 5 reductase and cytochrome P450 reductase to generate reactive oxygen species during redox cycling may compromise microsomal functioning including xenobiotic metabolism. However, redox cycling enzymes such as various aldo-keto reductases and cytochrome P450s can also metabolize various redox active chemicals. Together with various cellular antioxidants, these detoxifying enzymes are important in limiting tissue damage resulting from exposure to redox active chemicals.
It is well recognized that estrogens are an important risk factor for the development of breast cancer (Santen et al., 2015) . Estrogens can be metabolized to catechols, as well as reactive quinones and semiquinones (Parl et al., 2009) . Catechol estrogens are known to redox cycle, and their ability to generate cytotoxic reactive oxygen species may contribute to the carcinogenic process (Parl et al., 2009 ). Both breast cancer epithelial cells and purified NADPH cytochrome P450 reductase mediate catechol estrogen redox cycling and generate reactive oxygen species (Fussell et al., 2011) . The present studies demonstrate that cytochrome b 5 reductase mediates redox cycling of certain catechol estrogens. Depending on the localized concentrations of catechol estrogens and enzymes that mediate redox cycling such as cytochrome b 5 reductase, this may be an important mechanism contributing to the development of breast cancer.
Nitrofurantoin is a commonly used nitroaromatic redox-active antibiotic; it has also been used as an antitumor agent (Kamat and Lamm, 2004; Oscier et al., 2002) . Adverse reactions to the drug, which include liver injury (Paiva et al., 1992) , pulmonary fibrosis (Witten, 1989) , hematological disorders (Gait, 1990) , and peripheral polyneuropathy (Jacknowitz et al., 1977) , are thought to be due to the generation of reactive oxygen species during redox cycling (Martin 2nd, 1983; Rossi et al., 1988) . Our data showing that cytochrome b 5 reductase mediates nitrofurantoin redox cycling indicates that this enzyme may be an offtarget for the drug. Redox cycling by cytochrome b 5 reductase, as well as other enzymes reported to redox cycle nitroaromatic compounds, including nitric oxide synthase (Boelsterli et al., 2006) , thioredoxin reductase (Cenas et al., 2006) , ferredoxin:NADP+ reductase (Miskiniene et al., 1997) and cytochrome P450 reductase (Wang et al., 2008 ) may contribute to cytotoxicity of nitrofurantoin. Inhibition of the production of reactive oxygen species by these enzymes during redox cycling might translate into improved medical use of nitrofurantoin and related drugs.
Of interest were our findings that chemical redox cycling was associated with inhibition of the cytochrome b 5 reduction by cytochrome b 5 reductase. This was oxygen-dependent, a finding consistent with the fact that oxygen is required for quinone redox cycling by cytochrome b 5 reductase. Cytochrome b 5 reductase catalyzes electron transfer from NADH, a two electron carrier, to cytochrome b 5 , a one electron carrier, via FAD binding domains (Strittmatter, 1965) . Transfer of electrons from NADH generates a fully reduced form of FAD while transfer of single electrons to cytochrome b 5 generates FAD semiquinone intermediates. Redox cycling presumably occurs via single electron transfer between FAD, semiquinones and the redox active chemical. Inhibition of cytochrome b 5 reduction of cytochrome b 5 as a result of redox cycling is likely because this is an energetically favorable process (Iyanagi et al., 1984) . Thus, electrons preferentially transfer to redox active chemicals at the expense of the reduction of cytochrome b 5 . Inhibition of cytochrome b 5 reduction may result in deficiencies in processes dependent on this cofactor including fatty acid and cholesterol synthesis, methemoglobin and cytoglobin reduction, and xenobiotic oxidation (Amdahl et al., 2017; Galeeva et al., 2013; Guengerich, 2005; Hudspeth et al., 2010; Nagai et al., 1993; Xu et al., 2011) . Interestingly, high doses of primaquine, a quinone used to treat malaria, have been shown to induce methemoglobinemia in humans (Carmona-Fonseca et al., 2009; Kantor, 1992; Sin and Shafran, 1996) and this may be due to redox cycling. However, the extent to which redox cycling affects different metabolic pathways mediated by cytochrome b 5 reductase/cytochrome b 5 remains to be determined. In summary, the present studies show that cytochrome b 5 reductasemediated redox cycling, not only generates cytotoxic reactive oxygen species, but also has the capacity to reduce localized concentrations of intracellular oxygen and reducing equivalents from pyridine nucleotide cofactors, which can contribute to tissue damage. These activities, together with the inhibition of cytochrome b 5 reduction, are likely to contribute to cytotoxicity following exposure to quinones and other redox active chemicals. However, further studies are needed to determine how redox active chemicals bind to cytochrome b 5 reductase and the precise mechanism of electron transfer during redox cycling reactions.
